Radioimmunoassay (RIA)

Radioimmunoassay (RIA)

• 1.
  Radioimmunoassay (RIA) (Pooja Pawar-MSc part1)
• 2.
  Introduction • One ofthe most sensitive techniques for detecting antigen or antibody is radioimmunoassay (RIA). • The technique was first developed in 1960 by two endocrinologists, S. A. Berson and Rosalyn Yalow, to determine levels of insulin–anti-insulin complexes in diabetics. • In 1977, some years after Berson’s death, the significance of the technique was acknowledged by the award of a Nobel Prize to Yalow.
• 3.
  Principle • The principleof RIA involves competitive binding of radiolabeled antigen and unlabeled antigen to a high-affinity antibody. • The labeled antigen is mixed with antibody at a concentration that saturates the antigen-binding sites of the antibody. • Then test samples of unlabeled antigen of unknown concentration are added in progressively larger amounts.
• 4.
  • The antibodydoes not distinguish labeled from unlabeled antigen, so the two kinds of antigen compete for available binding sites on the antibody. • As the concentration of unlabeled antigen increases, more labeled antigen will be displaced from the binding sites. • The decrease in the amount of radiolabeled antigen bound to specific antibody in the presence of the test sample is measured in order to determine the amount of antigen present in the test sample.
• 5.
  • The antigenis generally labeled with a gamma-emitting isotope such as 125I, but beta-emitting isotopes such as tritium (3H) are also routinely used as labels. • The radiolabeled antigen is part of the assay mixture; the test sample may be a complex mixture, such as serum or other body fluids, that contains the unlabeled antigen.
• 6.
  Steps 1. The firststep in setting up an RIA is to determine the amount of antibody needed to bind 50%–70% of a fixed quantity of radioactive antigen (Ag∗) in the assay mixture. 2. This ratio of antibody to Ag∗ is chosen to ensure that the number of epitopes presented by the labeled antigen always exceeds the total number of antibody binding sites. 3. Consequently, unlabeled antigen added to the sample mixture will compete with radiolabeled antigen for the limited supply of antibody.
• 7.
   Even asmall amount of unlabeled antigen added to the assay mixture of labeled antigen and antibody will cause a decrease in the amount of radioactive antigen bound, and this decrease will be proportional to the amount of unlabeled antigen added.
• 8.
  Methods for separatingthe bound antigen from the free antigen in RIA • One method involves precipitating the Ag-Ab complex with a secondary anti-isotype antiserum. For example, if the Ag-Ab complex contains rabbit IgG antibody, then goat anti- rabbit IgG will bind to the rabbit IgG and precipitate the complex. • Another method makes use of the fact that protein A of Staphylococcus aureus has high affinity for IgG. If the Ag-Ab complex contains an IgG antibody, the complex can be precipitated by mixing with formalin-killed Staphylococcus aureus . • After removal of the complex by either of these methods, the amount of free labeled antigen remaining in the supernatant can be measured in a radiation counter; subtracting this value from the total amount of labeled antigen added yields the amount of labeled antigen bound.
• 9.
  Detection of Redioactivity •To determine the amount of labeled antigen bound, the Ag-Ab complex is precipitated to separate it from free antigen (antigen not bound to Ab), and the radioactivity in the precipitate is measured. • A standard curve can be generated using unlabeled antigen samples of known concentration, and from this plot the amount of antigen in the test mixture may be precisely determined.
• 12.
  Advantages • Radioimmunoassay iswidely used because of its great sensitivity. • Using antibodies of high affinity, it is possible to detect a few picograms of hormone to the tube. • The greater the specificity of the antiserum, the greater the specificity of the assay.
• 13.
  Limitations The main drawbacksto RIA are the expense & hazards of preparing & handling the radioactive antigen. The gamma emitting isotops such as 125I requires special counting equipments. Requires specially trained persons. Labs require special licence to handle radioactive materials. Requires special arrangements for - • Storage of radioactive materials • Radioactive waste disposal
• 14.
  RIA as amajor clinical tool Is is used to assay plasma levels of most of our hormones. Digitoxin or digoxin detection in patients receiving these drugs Certain abused drugs detection Narcotics drugs detection Early cancer detection Blood bank screening of Hepatitis virus